Compare ResMed Inc. (RMD) vs Invesco Solar ETF (TAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Invesco Solar ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Invesco Solar ETF trades at $53.77. The key difference: ResMed Inc. pays a 1.21% dividend while Invesco Solar ETF pays none, and Invesco Solar ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | TAN | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Sector/Thematic |
52-Week High | $293.73 | $73.95 |
52-Week Low | $182.82 | $36.07 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TAN trades at $52.69, down 2.24% with bearish technical signals showing 17 sell indicators versus 1 buy. The ETF faces headwinds from lower oil prices and regulatory uncertainty, though it benefits from growing data center energy demand and clean energy investment trends. Recent news highlights both opportunities in the AI-driven power boom and challenges from permit delays and geopolitical tensions affecting solar development.
The outlook remains cautious with technical deterioration and mixed sentiment. Long-term growth potential exists from energy transition trends, but near-term volatility and policy risks require careful monitoring. Investors should weigh exposure to utility-scale solar against competitive pressures and regulatory headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →
